PRESS RELEASE published on 03/28/2023 at 12:30, 3 years 6 months ago Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/20/2023 at 07:00, 3 years 6 months ago Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
PRESS RELEASE published on 03/17/2023 at 07:00, 3 years 7 months ago Newron to present at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/14/2023 at 07:00, 3 years 7 months ago Newron announces 2022 financial results and provides outlook for 2023
PRESS RELEASE published on 02/16/2023 at 07:00, 3 years 8 months ago Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
PRESS RELEASE published on 01/03/2023 at 07:00, 3 years 9 months ago Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
Published on 10/19/2026 at 09:05, 2 hours 29 minutes ago BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
Published on 10/17/2026 at 03:20, 2 days 8 hours ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 2 days 8 hours ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 2 days 11 hours ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 2 days 12 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/19/2026 at 11:16, 17 minutes ago On the way to a European lunar infrastructure: ESA awards OHB OASIS studies
Published on 10/19/2026 at 11:12, 21 minutes ago EQS-Adhoc: Katjes Greenfood sets volume of new 2026/2031 corporate bond at EUR 44 million
Published on 10/19/2026 at 08:15, 3 hours 19 minutes ago Carrefour strengthens its leadership in convenience retail in France with the acquisition of Codifrance
Published on 10/19/2026 at 08:15, 3 hours 19 minutes ago Carrefour renforce son leadership dans le commerce de proximité en France avec l’acquisition de Codifrance
Published on 10/16/2026 at 19:54, 2 days 15 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 2 days 16 hours ago Disclosure of transactions in own shares from October 12 to October 16, 2026
